Vaccination against Tetanus

Immunization against Tetanus

 

Rulebook on Immunization and Method of Medicinal Products Protection (“Official Gazette of the Republic of Serbia”, No. 82/2017)

Active and passive immunization against tetanus in injuries:

Article 29

Immunization against tetanus in injuries is carried out by a vaccine containing the TT component and human antithetical immunoglobulin (hereinafter: HTIG) in the following way:

1) persons with evidence that they have been fully vaccinated and revaccinated against tetanus for their age (at least four doses of the vaccine with the tetanus component), less than ten years have passed since the last dose to the injuries, neither receive a vaccine nor HTIG;

2) persons who have been fully vaccinated and revaccinated against tetanus for their age, and from the last dose to injury, more than ten years have passed, they receive one dose of vaccine and 250 IJ. HTIG, immediately after injury.

3) persons who have not been vaccinated, persons who have been fully vaccinated or have no evidence of immunization against tetanus, receive the first dose of the vaccine immediately, the second dose at intervals of not less than one month, and the third dose at least six months after the second dose. These individuals receive HTIG with the first dose of the vaccine immediately after the injury.

For the first dose, all vaccines containing the TT component (TT, Td, Tdap, DT) can be used depending on age. For the second and third doses, TT or dT / DT can be used depending on age. The vaccine and HTIG are administered simultaneously, intramuscularly to the nasal extremities, to the deltoid muscle or anterolateral part of the femoral region, depending on the age of the person receiving the vaccine according to the summary of the drug characteristics.